108 related articles for article (PubMed ID: 15830633)
1. Reconstitution of a hyperinflammatory prostaglandin E2 response to Porphyromonas gingivalis challenge in severe combined immunodeficient mice.
Salvi GE; Spets-Happonen S; Singer RE; Offenbacher S
J Periodontol; 2005 Jan; 76(1):16-21. PubMed ID: 15830633
[TBL] [Abstract][Full Text] [Related]
2. PGE2, IL-1 beta, and TNF-alpha responses in diabetics as modifiers of periodontal disease expression.
Salvi GE; Beck JD; Offenbacher S
Ann Periodontol; 1998 Jul; 3(1):40-50. PubMed ID: 9722689
[TBL] [Abstract][Full Text] [Related]
3. Inflammatory mediator response as a potential risk marker for periodontal diseases in insulin-dependent diabetes mellitus patients.
Salvi GE; Yalda B; Collins JG; Jones BH; Smith FW; Arnold RR; Offenbacher S
J Periodontol; 1997 Feb; 68(2):127-35. PubMed ID: 9058329
[TBL] [Abstract][Full Text] [Related]
4. Serum antibody levels against Porphyromonas gingivalis extract and its chromatographic fraction in chronic and aggressive periodontitis.
Trindade SC; Gomes-Filho IS; Meyer RJ; Vale VC; Pugliese L; Freire SM
J Int Acad Periodontol; 2008 Apr; 10(2):50-8. PubMed ID: 18564729
[TBL] [Abstract][Full Text] [Related]
5. Interleukin-8 and granulocyte elastase in gingival crevicular fluid in relation to periodontopathogens in untreated adult periodontitis.
Jin L; Söder B; Corbet EF
J Periodontol; 2000 Jun; 71(6):929-39. PubMed ID: 10914796
[TBL] [Abstract][Full Text] [Related]
6. Levels of interleukin-1 beta, -8, and -10 and RANTES in gingival crevicular fluid and cell populations in adult periodontitis patients and the effect of periodontal treatment.
Gamonal J; Acevedo A; Bascones A; Jorge O; Silva A
J Periodontol; 2000 Oct; 71(10):1535-45. PubMed ID: 11063385
[TBL] [Abstract][Full Text] [Related]
7. [Relationship between gingival crevicular fluid and serum specific antibody titers in periodontitis and changes after the treatment].
OuYang XY
Zhonghua Kou Qiang Yi Xue Za Zhi; 1993 Sep; 28(5):312-4, 319. PubMed ID: 8194427
[TBL] [Abstract][Full Text] [Related]
8. Immune responses to porphyromonas gingivalis infection suppress systemic inflammatory response in experimental murine model.
Naruishi K; Omori K; Maeda H; Sonoi N; Funakoshi K; Hirai K; Ishii M; Kubo K; Kobayashi H; Tomiyama T; Yamamoto D; Tanimoto I; Kunimatsu K; Takashiba S
J Biol Regul Homeost Agents; 2011; 25(2):195-202. PubMed ID: 21880208
[TBL] [Abstract][Full Text] [Related]
9. [Relationship of serum and gingival crevicular fluid antibody levels with the amount of subgingival homologous bacterium in patients with periodontal disease].
OuYang XY
Zhonghua Kou Qiang Yi Xue Za Zhi; 1994 Mar; 29(2):72-4, 127. PubMed ID: 8001430
[TBL] [Abstract][Full Text] [Related]
10. Porphyromonas gingivalis-induced inflammatory mediator profile in an ex vivo human whole blood model.
Bodet C; Chandad F; Grenier D
Clin Exp Immunol; 2006 Jan; 143(1):50-7. PubMed ID: 16367933
[TBL] [Abstract][Full Text] [Related]
11. Gingival crevicular fluid laminin-5 gamma2-chain levels in periodontal disease.
Emingil G; Kuula H; Pirilä E; Atilla G; Sorsa T
J Clin Periodontol; 2006 Jul; 33(7):462-8. PubMed ID: 16820033
[TBL] [Abstract][Full Text] [Related]
12. Antibodies to Bacteroides gingivalis in patients with treated and untreated periodontal disease.
Murray PA; Burstein DA; Winkler JR
J Periodontol; 1989 Feb; 60(2):96-103. PubMed ID: 2656978
[TBL] [Abstract][Full Text] [Related]
13. Effects of ketorolac tromethamine mouthrinse (0.1%) on crevicular fluid prostaglandin E2 concentrations in untreated chronic periodontitis.
Preshaw PM; Lauffart B; Brown P; Zak E; Heasman PA
J Periodontol; 1998 Jul; 69(7):777-83. PubMed ID: 9706855
[TBL] [Abstract][Full Text] [Related]
14. The effect of aspirin on gingival crevicular fluid levels of inflammatory and anti-inflammatory mediators in patients with gingivitis.
Kim DM; Koszeghy KL; Badovinac RL; Kawai T; Hosokawa I; Howell TH; Karimbux NY
J Periodontol; 2007 Aug; 78(8):1620-6. PubMed ID: 17668982
[TBL] [Abstract][Full Text] [Related]
15. Strain-dependent activation of the mouse immune response is correlated with Porphyromonas gingivalis-induced experimental periodontitis.
Wilensky A; Polak D; Awawdi S; Halabi A; Shapira L; Houri-Haddad Y
J Clin Periodontol; 2009 Nov; 36(11):915-21. PubMed ID: 19735468
[TBL] [Abstract][Full Text] [Related]
16. Effect of initial therapy on dynamics of immunogloblin G levels to some periodontopathic bacteria in serum and gingival crevicular fluid.
Hosaka Y; Saito A; Nakagawa T; Seida K; Yamada S; Okuda K
Bull Tokyo Dent Coll; 1994 Nov; 35(4):207-16. PubMed ID: 8689734
[TBL] [Abstract][Full Text] [Related]
17. Levels of specific immunoglobulin G to Porphyromonas gingivalis in gingival crevicular fluid are related to site disease status.
Mooney J; Kinane DF
Oral Microbiol Immunol; 1997 Apr; 12(2):112-6. PubMed ID: 9227135
[TBL] [Abstract][Full Text] [Related]
18. Mouse model of experimental periodontitis induced by Porphyromonas gingivalis/Fusobacterium nucleatum infection: bone loss and host response.
Polak D; Wilensky A; Shapira L; Halabi A; Goldstein D; Weiss EI; Houri-Haddad Y
J Clin Periodontol; 2009 May; 36(5):406-10. PubMed ID: 19419440
[TBL] [Abstract][Full Text] [Related]
19. Effects of treatment on antibody titer to Porphyromonas gingivalis in gingival crevicular fluid of patients with rapidly progressive periodontitis.
Johnson V; Johnson BD; Sims TJ; Whitney CW; Moncla BJ; Engel LD; Page RC
J Periodontol; 1993 Jun; 64(6):559-65. PubMed ID: 8393109
[TBL] [Abstract][Full Text] [Related]
20. The effects of interleukin-10 depletion in vivo on the immune response to Porphyromonas gingivalis in a murine model.
Herminajeng E; Sosroseno W; Bird PS; Seymour GJ
J Periodontol; 2001 Nov; 72(11):1527-34. PubMed ID: 11759864
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
